Comparison of the GPVI inhibitors losartan and honokiol

Marie-Blanche Onselaer, Magdolna Nagy, Chiara Pallini, Jeremy A. Pike, Gina Perrella, Lourdes Garcia Quintanilla, Johannes A. Eble, Natalie S. Poulter, Johan W. M. Heemskerk, Steve P. Watson*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)187-197
Number of pages11
JournalPlatelets
Volume31
Issue number2
DOIs
Publication statusPublished - 17 Feb 2020

Keywords

  • CLEC-2
  • GPVI
  • honokiol
  • losartan
  • platelets
  • RECEPTOR GLYCOPROTEIN VI
  • PLATELET ACTIVATION
  • FIBRIN
  • ANTAGONIST
  • SYK

Cite this

Onselaer, M-B., Nagy, M., Pallini, C., Pike, J. A., Perrella, G., Quintanilla, L. G., Eble, J. A., Poulter, N. S., Heemskerk, J. W. M., & Watson, S. P. (2020). Comparison of the GPVI inhibitors losartan and honokiol. Platelets, 31(2), 187-197. https://doi.org/10.1080/09537104.2019.1585526